Stereocontrolled synthesis of the four 16-hydroxymethyl-19-nortestosterone isomers and their antiproliferative activities
Abstract Novel 16-hydroxymethyl-19-nortestosterone diastereomers were prepared by Birch reduction from the corresponding 3-methoxy-16-hydroxymethylestra-1,3,5(10)-trien-17-ol isomers with known configurations. The synthetized compounds are 16α- and 16β-hydroxymethyl-substituted 19-nortestosterone an...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2016
|
| Sorozat: | STEROIDS
105 |
| doi: | 10.1016/j.steroids.2015.12.003 |
| mtmt: | 2982886 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/6918 |
| LEADER | 02451nab a2200313 i 4500 | ||
|---|---|---|---|
| 001 | publ6918 | ||
| 005 | 20190311133001.0 | ||
| 008 | 160601s2016 hu o 0|| zxx d | ||
| 022 | |a 0039-128X | ||
| 024 | 7 | |a 10.1016/j.steroids.2015.12.003 |2 doi | |
| 024 | 7 | |a 2982886 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Schneider Gyula | |
| 245 | 1 | 0 | |a Stereocontrolled synthesis of the four 16-hydroxymethyl-19-nortestosterone isomers and their antiproliferative activities |h [elektronikus dokumentum] / |c Schneider Gyula |
| 260 | |c 2016 | ||
| 300 | |a 113-120 | ||
| 490 | 0 | |a STEROIDS |v 105 | |
| 520 | 3 | |a Abstract Novel 16-hydroxymethyl-19-nortestosterone diastereomers were prepared by Birch reduction from the corresponding 3-methoxy-16-hydroxymethylestra-1,3,5(10)-trien-17-ol isomers with known configurations. The synthetized compounds are 16α- and 16β-hydroxymethyl-substituted 19-nortestosterone and their 17α-epimers. To prepare 17α-19-nortestosterone, the Mitsunobu inversion reaction of 19-nortestosterone with different alkyl and aryl carboxylic acids was chosen. Desacylation of the new compounds by the Zemplén method yielded the required 17α-19-nortestosterone. The antiproliferative activities of the structurally related compounds were determined in vitro through microculture tetrazolium assays on a panel of human adherent cervical (HeLa, SiHa and C33A), breast (MCF-7, MDA-MB-231, MDA-MB-361 and T47D) and ovarian (A2780) cell lines. The 17α epimer of 19-nortestosterone demonstrated considerable activity, selectively for HeLa cells, with a calculated IC50 of 0.65 μM. The reference compound, cisplatin, displayed an order of magnitude higher IC50 (12.4 μM). The cancer selectivity of 17α-19-nortestosterone was tested by MTT assay performed with noncancerous human fibroblast cell line MRC-5. The results indicated that 17α-19-nortestosterone selectively disturbs the viability of HeLa cells without greatly affecting other cancer cell types and intact fibroblasts. | |
| 700 | 0 | 1 | |a Kiss Anita |e aut |
| 700 | 0 | 1 | |a Mernyák Erzsébet |e aut |
| 700 | 0 | 1 | |a Benke Zsanett Amália |e aut |
| 700 | 0 | 1 | |a Wölfling János |e aut |
| 700 | 0 | 2 | |a Nagyné Frank Éva |e aut |
| 700 | 0 | 2 | |a Bózsity Noémi |e aut |
| 700 | 0 | 2 | |a Gyovai András |e aut |
| 700 | 0 | 2 | |a Minorics Renáta |e aut |
| 700 | 0 | 2 | |a Zupkó István |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/6918/1/148_Steroids_2016.pdf |z Dokumentum-elérés |